CoChat
Sign Up
Cited by 87

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Human Papillomavirus 16 E5 Inhibits Interferon Signaling and Supports Episomal Viral Maintenance

Scott, Matthew L., Woodby, Brittany L., Ulicny, Joseph, Raikhy, Gaurav, Orr, A. Wayne, Songock, William K., Bodily, Jason M.·2020·Journal of Virology
DOI 10.1128/jvi.01582-19
Open this paper in CoChat — free account

Abstract

Persistent human papillomavirus infections can cause a variety of significant cancers. The ability of HPV to persist depends on evasion of the host immune system. In this study, we show that the HPV16 E5 protein can suppress an important aspect of the host immune response. In addition, we find that the E5 protein is important for helping the virus avoid integration into the host genome, which is a frequent step along the pathway to cancer development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jvi.01582-19

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 125

  1. 10.1136/sti.60.3.182 · DOI
  2. 10.5402/2012/854237 · DOI
  3. 10.1016/j.vaccine.2012.05.089 · DOI
  4. 10.1073/pnas.91.7.2436 · DOI
  5. 10.1042/BST0351456 · DOI
  6. 10.4049/jimmunol.169.9.4822 · DOI
  7. 10.1007/bf00456841 · DOI
  8. Stanley MA. 2009. Immune responses to human papilloma viruses. Indian J Med Res 130:266–276.
  9. 10.1016/bs.pmbts.2016.09.003 · DOI
  10. 10.1016/j.virol.2008.10.004 · DOI
  11. 10.1093/jnci/91.3.226 · DOI
  12. 10.1002/(sici)1097-0215(19990730)82:3<334::aid-ijc5>3.0.co;2-c · DOI
  13. 10.1128/CDLI.8.2.209-220.2001 · DOI
  14. 10.1002/ijc.21443 · DOI
  15. 10.1097/00001622-200409000-00008 · DOI
  16. 10.1136/mp.55.1.19 · DOI
  17. 10.1001/jama.283.8.1031 · DOI
  18. 10.1016/j.tim.2010.10.002 · DOI
  19. 10.1128/jvi.77.5.2819-2831.2003 · DOI
  20. 10.1128/jvi.77.5.2832-2842.2003 · DOI
  21. 10.1006/excr.1998.4024 · DOI · Paper page
  22. Pim D, Collins M, Banks L. 1992. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7:27–32.
  23. 10.1128/jvi.67.8.4521-4532.1993 · DOI · Paper page
  24. 10.1128/jvi.69.5.3185-3192.1995 · DOI
  25. 10.1078/0171-9335-00060 · DOI · Paper page
  26. 10.1016/j.virol.2018.03.021 · DOI · Paper page
  27. 10.1186/1476-4598-12-38 · DOI
  28. 10.1101/sqb.1999.64.149 · DOI
  29. 10.1101/sqb.1998.63.609 · DOI
  30. 10.1016/j.bbagrm.2010.01.010 · DOI
  31. 10.1146/annurev.immunol.19.1.623 · DOI · Paper page
  32. 10.1016/S0940-2993(96)80039-X · DOI
  33. 10.1038/nri2622 · DOI
  34. 10.1016/0167-5699(93)90062-P · DOI
  35. 10.1002/jlb.66.1.33 · DOI
  36. 10.1128/JVI.02571-05 · DOI
  37. 10.1016/0024-3205(96)00042-2 · DOI
  38. 10.1074/jbc.M102502200 · DOI
  39. 10.1128/JVI.75.9.4283-4296.2001 · DOI
  40. 10.1128/jvi.74.9.4174-4182.2000 · DOI
  41. 10.1158/0008-5472.CAN-06-3619 · DOI
  42. 10.1002/ijc.23463 · DOI
  43. Nees M, Geoghegan JM, Munson P, Prabhu V, Liu Y, Androphy E, Woodworth CD. 2000. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Cancer Res 60:4289–4298.
  44. 10.1128/JVI.75.16.7564-7571.2001 · DOI
  45. 10.1016/j.virol.2013.08.036 · DOI
  46. 10.1128/JVI.05279-11 · DOI · Paper page
  47. 10.3892/ijo.11.1.169 · DOI
  48. 10.1038/labinvest.2010.95 · DOI
  49. 10.1158/0008-5472.CAN-09-0550 · DOI
  50. 10.1371/journal.pone.0091473 · DOI
  51. 10.18632/oncotarget.10013 · DOI
  52. 10.1128/JVI.80.9.4422-4430.2006 · DOI
  53. 10.1128/JVI.00688-11 · DOI
  54. 10.1038/onc.2014.331 · DOI
  55. 10.7883/yoken.52.45 · DOI
  56. 10.1016/S0002-9440(10)63654-1 · DOI
  57. 10.1002/hep.26404 · DOI
  58. 10.1152/ajplung.00368.2013 · DOI
  59. 10.1371/journal.pone.0044580 · DOI
  60. 10.1128/mcb.24.3.1411-1425.2004 · DOI
  61. 10.1128/JVI.01714-17 · DOI
  62. 10.1093/carcin/bgu050 · DOI
  63. 10.1128/JVI.00664-11 · DOI
  64. 10.1016/j.virol.2013.05.006 · DOI
  65. Piboonniyom SO, Duensing S, Swilling NW, Hasskarl J, Hinds PW, Munger K. 2003. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res 63:476–483.
  66. 10.1128/mBio.00845-13 · DOI
  67. 10.1371/journal.ppat.1006660 · DOI
  68. 10.1038/emboj.2008.241 · DOI
  69. 10.1016/S0021-9258(19)50182-X · DOI
  70. 10.1186/gb-2007-8-9-r183 · DOI
  71. 10.1093/nar/gkm415 · DOI
  72. 10.1007/s00018-005-5561-x · DOI
  73. 10.18632/oncotarget.10959 · DOI
  74. 10.1038/sj.onc.1204733 · DOI
  75. 10.1038/sj.onc.1201312 · DOI · Paper page
  76. 10.1023/A:1008112207824 · DOI · Paper page
  77. 10.18632/oncotarget.21658 · DOI
  78. 10.1128/JVI.00513-16 · DOI
  79. 10.1093/emboj/18.18.5061 · DOI · Paper page
  80. 10.1371/journal.pone.0187514 · DOI
  81. 10.1016/j.bbrc.2009.08.019 · DOI
  82. 10.1074/jbc.M201884200 · DOI
  83. 10.1016/j.virol.2011.12.023 · DOI
  84. 10.1371/journal.pone.0017848 · DOI
  85. 10.1038/ncomms7537 · DOI
  86. 10.1038/jid.2014.262 · DOI
  87. Da Costa R, Bastos MM, Medeiros R, Oliveira PA. 2016. The NFkappaB signaling pathway in papillomavirus-induced lesions: friend or foe?. Anticancer Res 36:2073–2083.
  88. 10.1101/gad.1643908 · DOI
  89. 10.1016/j.cytogfr.2006.01.004 · DOI
  90. 10.1038/sj.onc.1205134 · DOI
  91. 10.1038/sj.cdd.4401914 · DOI
  92. 10.3390/ijms18102227 · DOI
  93. 10.1074/jbc.C111.284620 · DOI
  94. 10.1016/j.ygeno.2014.08.012 · DOI
  95. 10.1134/S0026893310050110 · DOI
  96. 10.1016/j.bbagrm.2014.09.014 · DOI
  97. 10.1128/MCB.00246-08 · DOI
  98. 10.1093/carcin/bgl172 · DOI
  99. 10.1073/pnas.0600078103 · DOI
  100. 10.1128/JVI.05007-11 · DOI
  101. 10.1128/jvi.76.17.8864-8874.2002 · DOI
  102. Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley MA, Coleman N. 2002. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res 62:6959–6965.
  103. 10.1093/carcin/bgu236 · DOI
  104. 10.1016/j.bpobgyn.2017.08.001 · DOI
  105. 10.1128/JVI.01194-10 · DOI
  106. 10.1074/jbc.275.10.6764 · DOI · Paper page
  107. 10.1101/gad.12.13.2061 · DOI · Paper page
  108. 10.3892/ijmm.5.6.661 · DOI
  109. 10.1016/s0304-3835(01)00871-0 · DOI
  110. 10.1128/JVI.00998-10 · DOI
  111. 10.1016/j.gene.2005.10.018 · DOI
  112. 10.1128/mcb.16.10.5276 · DOI
  113. 10.1074/jbc.M605136200 · DOI
  114. 10.1038/sj.onc.1209768 · DOI
  115. 10.1038/nchem.2064 · DOI
  116. Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM. 1985. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119:361–366.
  117. 10.1099/0022-1317-68-2-583 · DOI
  118. 10.1038/314111a0 · DOI
  119. 10.1002/j.1460-2075.1987.tb02662.x · DOI
  120. 10.1128/jvi.61.4.962-971.1987 · DOI
  121. 10.1128/jvi.69.5.2989-2997.1995 · DOI
  122. 10.1136/mp.52.5.275 · DOI
  123. 10.1158/0008-5472.CAN-08-3099 · DOI
  124. 10.1385/1-59259-982-6:157 · DOI
  125. 10.1016/j.virol.2009.02.036 · DOI

Cited by

Metadata

Authors
Scott, M. L., Woodby, B. L., Ulicny, J., Raikhy, G., Orr, A. W., Songock, W. K., & Bodily, J. M.
Affiliations
  • Department of Microbiology and Immunology, Center for Molecular and Tumor Virology, and Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
  • School of Medicine, Louisiana State University Health Sciences Center—Shreveport, Shreveport Louisiana, USA
  • Department of Pathology and Translational Pathobiology, Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center—Shreveport, Shreveport, Louisiana, USA
  • Department of Biology, Centenary College of Louisiana, Shreveport, Louisiana, USA
Venue
Journal of Virology
Publisher
American Society for Microbiology
Published
2020-01-06
Volume
94
Issue
2
ISSN
  • 0022-538X
  • 1098-5514
DOI
10.1128/jvi.01582-19
Cited by
87
References
6
Language
en
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Funders
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI118904)
  • HHS | NIH | National Institute of General Medical Sciences (P30GM110703)
  • HHS | NIH | National Heart, Lung, and Blood Institute (HL141155)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review